Kamu erişimi zorunlu olan makaleler - Eric DelaporteDaha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 7
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open …
A Calmy, TT Sanchez, C Kouanfack, M Mpoudi-Etame, S Leroy, ...
The lancet HIV 7 (10), e677-e687, 2020
Zorunlu olanlar: World Health Organization, Agence Nationale de la Recherche
High viral load and multidrug resistance due to late switch to second-line regimens could be a major obstacle to reach the 90-90-90 UNAIDS objectives in sub-Saharan Africa
E Guichet, A Aghokeng, L Serrano, G Bado, C Toure-Kane, ...
AIDS Research and Human Retroviruses 32 (12), 1159-1162, 2016
Zorunlu olanlar: National Institute of Health and Medical Research, France
Nonhuman primate retroviruses from Cambodia: high simian foamy virus prevalence, identification of divergent STLV-1 strains and no evidence of SIV infection
A Ayouba, L Duval, F Liégeois, S Ngin, S Ahuka-Mundeke, WM Switzer, ...
Infection, Genetics and Evolution 18, 325-334, 2013
Zorunlu olanlar: US National Institutes of Health
Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational …
A Nkuba-Ndaye, A Dilu-Keti, T Tovar-Sanchez, MSK Diallo, ...
The Lancet Infectious Diseases 24 (3), 266-274, 2024
Zorunlu olanlar: National Institute of Health and Medical Research, France, Agence Nationale …
Improvements in patient-reported outcomes following initiation of dolutegravir-based or low-dose efavirenz-based first-line antiretroviral therapy: a four-year longitudinal …
C Protopopescu, M Mpoudi-Etame, PO Bassega, G Maradan, J Olinga, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 94 (3), 262-272, 2023
Zorunlu olanlar: National Institute of Health and Medical Research, France, World Health …
Low CD4 counts predict excessive weight gains during first-line treatment for HIV
A Hill, T Tovar Sanchez, E Delaporte, S Sokhela, B Simmons, ...
Journal of Antimicrobial Chemotherapy 79 (9), 2369-2378, 2024
Zorunlu olanlar: World Health Organization, Agence Nationale de la Recherche
Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials
F Venter, S Sokhela, A Calmy, MJ Siedner, S Khoo, P Clayden, ...
AIDS 36 (13), 1900-1901, 2022
Zorunlu olanlar: US National Institutes of Health, US Agency for International Development
Bir yerde sunuluyor: 120
Origin of the human malaria parasite Plasmodium falciparum in gorillas
W Liu, Y Li, GH Learn, RS Rudicell, JD Robertson, BF Keele, ...
Nature 467 (7314), 420-425, 2010
Zorunlu olanlar: US National Institutes of Health, Howard Hughes Medical Institute
Origin of the HIV-1 group O epidemic in western lowland gorillas
M D’arc, A Ayouba, A Esteban, GH Learn, V Boué, F Liegeois, L Etienne, ...
Proceedings of the National Academy of Sciences 112 (11), E1343-E1352, 2015
Zorunlu olanlar: US National Institutes of Health, Wellcome Trust
Dolutegravir-based or low-dose efavirenz–based regimen for the treatment of HIV-1
Namsal Anrs 12313 Study Group
New England Journal of Medicine 381 (9), 816-826, 2019
Zorunlu olanlar: World Health Organization, Agence Nationale de la Recherche
African origin of the malaria parasite Plasmodium vivax
W Liu, Y Li, KS Shaw, GH Learn, LJ Plenderleith, JA Malenke, ...
Nature communications 5 (1), 3346, 2014
Zorunlu olanlar: US National Institutes of Health, UK Medical Research Council, Wellcome Trust
Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks
AK Keita, FR Koundouno, M Faye, A Düx, J Hinzmann, H Diallo, ...
Nature 597 (7877), 539-543, 2021
Zorunlu olanlar: Research Foundation (Flanders), National Institute of Health and Medical …
Sustained human outbreak of a new MPXV clade I lineage in eastern Democratic Republic of the Congo
EH Vakaniaki, C Kacita, E Kinganda-Lusamaki, Á O’toole, ...
Nature medicine 30 (10), 2791-2795, 2024
Zorunlu olanlar: Wellcome Trust, Agence Nationale de la Recherche
The origin and diversity of human retroviruses
M Peeters, M D’Arc, E Delaporte
AIDS reviews 16 (1), 23, 2014
Zorunlu olanlar: US National Institutes of Health
Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions
AF Aghokeng, A Ayouba, E Mpoudi-Ngole, S Loul, F Liegeois, ...
Infection, Genetics and Evolution 10 (3), 386-396, 2010
Zorunlu olanlar: US National Institutes of Health
Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study
JF Etard, MS Sow, S Leroy, A Touré, B Taverne, P Msellati, S Baize, ...
The Lancet Infectious Diseases 17 (5), 545-552, 2017
Zorunlu olanlar: National Institute of Health and Medical Research, France
Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas
C Neel, L Etienne, Y Li, J Takehisa, RS Rudicell, I Ndong Bass, ...
Journal of virology 84 (3), 1464-1476, 2010
Zorunlu olanlar: US National Institutes of Health
Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Côte d’Ivoire
A Ayouba, C Akoua-Koffi, S Calvignac-Spencer, A Esteban, S Locatelli, ...
Aids 27 (15), 2488-2491, 2013
Zorunlu olanlar: US National Institutes of Health, German Research Foundation
Depressive symptoms among survivors of Ebola virus disease in Conakry (Guinea): preliminary results of the PostEboGui cohort
MM Keita, B Taverne, S Sy Savané, L March, M Doukoure, MS Sow, ...
BMC psychiatry 17, 1-9, 2017
Zorunlu olanlar: National Institute of Health and Medical Research, France
Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon …
C Laurent, C Kouanfack, G Laborde-Balen, AF Aghokeng, JBT Mbougua, ...
The Lancet infectious diseases 11 (11), 825-833, 2011
Zorunlu olanlar: National Institute of Health and Medical Research, France
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir